Choose your country to see the products for your location
We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! Very soon, the first batch of flagship products will be available on the market under the new IVDR, well in advance of the transition period deadline.
Effective from 1 January 2025, we will be implementing a price increase of approximately 1.9% on most of our products.
MRC Holland will be closed from December 25, 2024 until January 2, 2025.
SALSA MLPA Probemix P369 Smith-Magenis, designed for copy number detection of the 17p11.2 and 2q37.3 regions, has just received a major update with several improved or new target and reference probes.
ME030 BWS/RSS has been updated to ensure an even more robust assay output with several improved target and reference probes and a new digestion control probe.
Have you checked out the new version of our digitalMLPA General Protocol? We have summarized the most important changes in this news item.
A recent study using D001 Hereditary Cancer Panel 1 shed light on increasing trend of mesothelioma diagnosis.
In June, we celebrated a significant milestone: several MRC Holland products have received a positive recommendation for IVDR certification!
MRC Holland is dedicated to ensuring our products align with the latest European In Vitro Diagnostic Regulation (IVDR). Here is a brief overview of our progress.
MRC Holland is looking for DNA samples for the development and quality control of our many products.
Join our mailing list to receive the latest information about our products, technologies and website.